Spinraza access agreement extended to include more people
Dear community, Please find below the official press release from NICE.
Category: Updates
New MAA with revised entry criteria released by NICE
TreatSMA response to the latest release of the MAA released by NICE today
Spinraza access agreement extended to include more people
Dear community, Please find below the official press release from NICE.
New MAA with revised entry criteria released by NICE
TreatSMA response to the latest release of the MAA released by NICE today
Biogen Announces New NURTURE Data
At the CureSMA conference this year Biogen on 1st July 2019 published new results from the NURTURE study.
Scotland can now access nusinersen (Spinraza®️) for types 2 and 3
Following recent communication from the Scottish Government, the Scottish Medicines Consortium have now provided guidance that, as well as being available for those with SMA Type 1, from July 2019 nusinersen can be prescribed for those with SMA Types 2 and 3.
Biogen Announces New NURTURE Data
At the CureSMA conference this year Biogen on 1st July 2019 published new results from the NURTURE study.
Scotland can now access nusinersen (Spinraza®️) for types 2 and 3
Following recent communication from the Scottish Government, the Scottish Medicines Consortium have now provided guidance that, as well as being available for those with SMA Type 1, from July 2019 nusinersen can be prescribed for those with SMA Types 2 and 3.